Market capitalization | $8.05m |
Enterprise Value | $-6.64m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 0.99 |
EV/Sales (TTM) EV/Sales | -1.76 |
P/S ratio (TTM) P/S ratio | 2.14 |
P/B ratio (TTM) P/B ratio | 0.50 |
Revenue growth (TTM) Revenue growth | -41.41% |
Revenue (TTM) Revenue | $3.77m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast NeuroMetrix, Inc.:
1 Analyst has issued a forecast NeuroMetrix, Inc.:
Sep '24 |
+/-
%
|
||
Revenue | 3.77 3.77 |
41%
41%
|
|
Gross Profit | 2.17 2.17 |
50%
50%
|
|
EBITDA | -8.48 -8.48 |
40%
40%
|
EBIT (Operating Income) EBIT | -8.68 -8.68 |
41%
41%
|
Net Profit | -7.68 -7.68 |
38%
38%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
Head office | United States |
CEO | Shai Gozani |
Employees | 26 |
Founded | 1996 |
Website | www.neurometrix.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.